Health3 years ago
FDA Approval of Alzheimer’s drug prompts advisors to resign
Three members of the FDA’s advisory panel have resigned in protest against the agency’s decision to approve Biogen Inc’s Alzheimer’s treatment. Dr. Joel Perlmutter, Dr. David...